Clearmind Medicine Inc. (Nasdaq: CMND) a clinical stage biotech company developing psychedelic-derived treatment solutions, today announced the initiation of its Phase I/IIa clinical trial at the…
Clearmind Medicine Inc. (Nasdaq: CMND) a clinical stage biotech company developing psychedelic-derived treatment solutions, today announced the initiation of its Phase I/IIa clinical trial at the…